MedPath

Influence of Sodium Intake in spondyLoarthriTes

Not Applicable
Recruiting
Conditions
Spondyloarthritis, Axial
Arthritis, Psoriatic
Registration Number
NCT06259890
Lead Sponsor
Centre Hospitalier Universitaire de Besancon
Brief Summary

The aim of the SALT study is to analyze the relationship between dietary sodium intake and disease activity in patients with axial spondyloarthritis (radiographic or non-radiographic) or psoriatic arthritis.

Detailed Description

Not available

Recruitment & Eligibility

Status
RECRUITING
Sex
All
Target Recruitment
250
Inclusion Criteria
  • patients with axial spondyloarthritis (radiographic or non-radiographic) or psoriatic arthritis
  • women who have been menopausal for at least 24 months, surgically sterilized, or, for women of childbearing potentiale, use an effective method of contraception (oral contraceptives, contraceptive injections, intrauterine devices, double-barrier method, contraceptive patches)
Exclusion Criteria
  • patient treated by cyclosporine, diuretics, angiotensin-converting enzyme inhibitors or angiotensin II receptor antagonists.
  • current treatment with an anti-IL-17A agent (secukinumab or ixekizumab or bimekizumab or brodalumab) or with an anti-IL23 agent (ustekinumab, guselkumab, risankizumab or tildrakizumab) or previous treatment less than 6 months old.
  • patients on systemic corticosteroids with corticosteroid therapy > 10 mg prednisone equivalent
  • pregnant woman

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Primary Outcome Measures
NameTimeMethod
sodium intakeday of inclusion, monday and tuesday following

average sodium concentration in urine for the week

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (4)

CHU Besançon

🇫🇷

Besancon, France

CHD Vendée

🇫🇷

La Roche-sur-Yon, France

CHU St Etienne

🇫🇷

St Etienne, France

Hôpital Nord Franche-Comté

🇫🇷

Trévenans, France

CHU Besançon
🇫🇷Besancon, France
Eric Toussirot, MD PhD
Principal Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.